HAE — Haemonetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Haemonetics, fiscal year end - March 30th, USD millions except per share, conversion factor applied.

	2020 March 28th	2021 April 3rd	2022 April 2nd	2023 April 1st	2024 March 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	137	192	259	284	179
Net Total Accounts Receivable
Net Total Receivables	165	128	159	179	207
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	604	694	756	770	769
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	306	277	311	364	367
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,267	1,820	1,860	1,935	2,196
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	275	253	442	252	300
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	680	1,088	1,110	1,117	1,236
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	587	732	749	818	960
Total Liabilities & Shareholders' Equity	1,267	1,820	1,860	1,935	2,196
Total Common Shares Outstanding